ArticleImmunologic research2026
Cell-based ELISA using intact HEp-2 cells: an alternative approach for antinuclear antibody detection.
Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntinuclear antibodies (ANAs) are serological markers of clinical importance in the diagnosis and monitoring of autoimmune diseases. This study aimed to develop a HEp-2 cell-based ELISA method as a quantitative and standardized alternative to traditional ANA detection techniques such as indirect immunofluorescence (IFA). MATERIALS AND
methodsHEp-2 cells were seeded in ELISA plates at ~ 3.0 × 10⁴ cells per well and incubated. After fixation with formaldehyde and acetone, cells were quenched with 1% H₂O₂, permeabilized using Triton X-100, acetone, and methanol, and blocked with Well Champion or 1% BSA. Sixteen sera (8 ANA-positive, 8 ANA-negative), confirmed by Chorus ANA-8 and DRG ANA-8-Screen ELISA, were applied. ANA levels were measured by indirect ELISA with OD readings at 450 nm. Three HRP-conjugated secondary antibodies (anti-IgG gamma chain, Fc-specific, whole IgG) were tested.
resultsFixation and permeabilization agents did not interfere with the distinction between ANA-positive and ANA-negative samples. In the absence of quenching and when 1% BSA was used for blocking, background levels increased. Among the secondary antibodies, the anti-IgG gamma chain showed the least cross-reactivity, while Fc-specific and whole IgG antibodies had higher nonspecific binding. The assay showed an average intra- and inter-assay variation of 13.13%, with a sensitivity of 87.5% and a specificity of 81.25%.
conclusionsThis study demonstrates that the HEp-2 cell-based ELISA is a feasible, promising method for detecting and quantifying ANA positivity. While it reliably distinguishes between positive and negative samples, it may serve as a practical alternative to conventional assays in research and diagnostics.
Indexed as
Identifiers
42560627What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.